Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Treatment Effects Maintained Over Five Years in Majority of Patients with Relapsing Remitting Multiple Sclerosis who Received Genzyme’s Lemtrada® (alemtuzumab) in Clinical Trials
Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen.
White matter tract abnormalities are associated with cognitive dysfunction in secondary progressive multiple sclerosis.
A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin.
A wireless body measurement system to study fatigue in multiple sclerosis.
Endovascular Treatment of Chronic Cerebro-Spinal Venous Insufficiency in Multiple Sclerosis: A retrospective study.
Dibutyryl Cyclic AMP Inhibits the Progression of Experimental Autoimmune Encephalomyelitis and Potentiates Recruitment of Endogenous Neural Stem Cells.
[The first results of a combined all-Russian study on clinical genetics of multiple sclerosis.]
Role of early viral infections in development of multiple sclerosis.
Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients.
We are about to cure multiple sclerosis in the next 10 years, even though we do not know its cause: Yes.
Acute Disseminated Encephalomyelitis Following 2009 H1N1 Influenza Vaccination.
Unilateral optic neuritis, scleritis and exudative retinal detachment due to recurrent orbital pseudotumor.
FDA Drug Safety Communication: FDA investigating rare brain infection in patient taking Gilenya (fingolimod)
Presence of aberrant V<formula>_{H}</formula>6 domains in anti-interferon-γ autoantibodies in multiple sclerosis.
Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG35-55-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice.
Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis.
Quantitative assessment of upper limb motor function in Multiple Sclerosis using an instrumented Action Research Arm Test.
Information provision for people with multiple sclerosis.
Bipolar disorder and multiple sclerosis: a case series.
Prevalence of temporomandibular disorders symptoms in patients with multiple sclerosis.
Tocilizumab treatment safety in rheumatoid arthritis in a patient with multiple sclerosis: a case report.
Contingent negative variation is associated with cognitive dysfunction and secondary progressive disease course in multiple sclerosis.
Database integration of protocol-specific neurological imaging datasets.
Epigenetics in NG2 glia cells.

Pages